Jay Widmer

Dr. Widmer is on the senior staff at Baylor Scott and White as an interventional/structural cardiologist, serving as a Clinical Assistant Professor for the Texas A&M College of Medicine, and was recently appointed director of the cardiac catheterization and electrophysiology labs. He achieved his undergraduate work at Southwestern University in Georgetown, TX and his combined MD/PhD at Texas A&M Health Sciences Center in 2009. He was then accepted to the clinical research track at Mayo in Rochester, MN. He concluded the second year of a combined interventional/structural cardiology fellowship after finishing an ABIM-sponsored clinical investigator program affiliated with Cardiovascular Diseases Fellowship. Additionally, Jay has completed the selective Mayo Clinic Physician Scientists Clinical Research Certificate program. Jay completed his Internal Medicine Training in June of 2012, general cardiology training in 2016, and interventional/structural cardiology training in 2018 with board certifications currently held in all three.

His interest in interventional cardiology began in a research lab just before beginning medical school while witnessing a cardiac catheterization procedure (porcine, no less), and has continued to mature as he begins a career as an academic interventionalist. His projects have resulted in over 70 peer-reviewed manuscripts and over 60 conference abstracts in the field of vascular biology, coronary physiology, cardiovascular outcomes/prevention, social media, and digital health. Dr. Widmer has continued all of these research interests while being junior faculty at Baylor Scott and White and has laid the groundwork for long-term success by becoming site principal investigator on multiple trials and building databases in non-obstructive coronary artery disease, chronic total occlusion PCI, cardio-oncology, and quality metrics for acute myocardial infarction. Notably, he was recently appointed the medical director for the BSWRI Central Texas Division, serves on the system-wide CV Governance Council, and was nominated to be in the most recent SCAI Emerging Medical Leaders Cohort.